You are here: All Products  > Athenex, a US-China biopharma, Files for $100 Million US IPO

Athenex, a US-China biopharma, Files for $100 Million US IPO

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products